Understanding vascular complications in children from type 1 diabetes diagnosis: protocol for a prospective cohort study in Vancouver, Canada.

introductionCardiovascular disease is a major complication of type 1 diabetes (T1D). There is evidence of cardiovascular damage in children who have T1D but it is unclear how and when the cardiovascular damage begins. There is also minimal data on cardiovascular complications in children with T1D living in Canada. The goal of this project is to determine the timing and factors leading to vascular damage in children (aged 8-18 years) from T1D diagnosis. METHODS AND ANALYSIS: This is a prospective longitudinal cohort study investigating vascular health in children through the first 2 years of T1D diagnosis living in Metro Vancouver, Canada. The primary outcomes of the study include changes in arterial stiffness (pulse wave velocity; Augmentation Index), clinic and 24-hour ambulatory blood pressure, and blood biomarkers of vascular damage. Secondary outcome measures include body composition, surrogate markers of adiposity (Body Mass Index, waist circumference), and nutritional assessment, physical activity, glycated haemoglobin (A1C), and to determine the relationships to measures of arterial stiffness, 24-hour ambulatory blood pressure and blood biomarkers of vascular damage. We will also collect sociodemographic data and pubertal status (Tanner staging). Assessments will be performed at diagnosis (within 14 weeks of T1D diagnosis; baseline) and at 6, 12, 18 and 24 months post-diagnosis. ETHICS AND DISSEMINATION: This protocol has been approved by the University of British Columbia Clinical Research Ethics Board and the Children's and Women's Health Centre of British Columbia Research Ethics Board (H21-03109). Results will be disseminated through clinical and community presentations and peer-reviewed manuscripts. We will also present our findings to people living with T1D, such as the Young & T1 group. TRIAL REGISTRATION NUMBER: NCT05790785.